| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-07 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-07 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-07 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.18 | 5e-07 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-07 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-06 |